In Phase A, participants will obtain distinctive doses and schedules of oral ABBV-744 tablet to discover Secure dosing regimen. Added contributors will likely be enrolled for the identified monotherapy dosign regimen. In Segment B, individuals will get oral ruxolitinib and ABBV-744 will likely be given as "add-on" therapy. In Segment https://isabbv-744effectiveforhem56879.blogunok.com/32194726/abbv-744-clinical-trial-phase-2-data-things-to-know-before-you-buy